Effect of hyperglycemia on serum uric acid levels - A real world comparative study
Keywords:
HYPERGLYCEMIA, Serum uric, diabetesAbstract
Objective: - To determine the relationship between hyperglycaemia and uric acid levels.
Material and methods:- Patients, with known diabetes or impaired glucose tolerance/newly detected patients of diabetes treated on OPD basis or in patients admitted in B.T.G.H over a period of 1yr from April 2017 to March 2018.
Study design: - randomized, comparative, cross-sectional.
Result: - 19 cases of type 2 DM had hypouricemia while 6 in controls .7 cases of IGT had hyperuricemia, 6 controls had hyperuricemia and none in patients with type 2 DM.
Conclusion:- Serum uric acid concentration is slightly reduced in patients with type 2 DM. Serum uric acid concentration is increased in patients with IGT
Downloads
INTRODUCTION
It is estimated globally 463 million adults are suffering from , the latest data (2019) from the International Diabetes Federation1. Diabetes prevalence is rapidly increasing. As per 2017 estimates 425 million people living with diabetes2. The number is projected to almost double by 2030. Several studies have shown there are evidences to suggest that low serum uric acid levels may precede the onset of diabetic retinopathy.
Plasma uric acid, an end product of purine metabolism3.Its levels are genetically determined but are influenced by multiple environmental factors. Recently, it has been shown that there is a definite relationship between hyperglycemia and uric acid levels4
Studies done so far have shown that, in the early stages of diabetes, the levels were high and as the diabetic status progresses there is gradual decline of uric acid levels in many patients5. It has been reported that hypouricemia may also predict the future progression and hence be an indicator of incipient nephropathy in Type2 DM.
Study design: Comparative study
Study location: B.T.G.H
Ethics approval: BTGH ethical committee.
Study period: April 2017 to March 2018.
Sample size: Approximately 100 patients 50 with impaired glucose tolerance test and/or patients with diabetes mellitus newly detected or already on treatment and 50 normal subjects
Inclusion criteria: Patients, with known diabetes or impaired glucose tolerance/newly detected patients of diabetes or impaired glucose tolerance treated on OPD basis or in patients. Patients already on treatment or freshly detected diabetes
Exclusion criteria
- Patients with BMI >30
- Patients with history of hypertension, alcoholic, myeloproliferative disorders, lymphoproliferative disorders, psoriasis
- Patients not capable of giving consent (psychiatric patients).
- Patients not willing to participate in the study (who refused to give consent)
- Pregnant and lactating women
Methodology:
Parameter used: - Serum uric acid levels, Random blood sugar levels, Impaired glucose tolerance test1.
STATISCAL ANALYSIS
- Statistical analysis was done using SPSS 16 software.
- Results were interpretedusing paired and unpaired t tests and chi square tests.
RESULTS
Sex | Type 2 DM | IGT | Controls | |||
NO. | % | NO. | % | NO. | % | |
MALE | 22 | 51.16 | 3 | 42.85 | 25 | 50 |
FEMALE | 21 | 48.84 | 4 | 57.15 | 25 | 50 |
TOTAL | 43 | 100 | 7 | 100 | 50 | 100 |
In relation to | Parameters | Cases | Control |
type 2 DM | Serum uric acid (mg/dl) | 3.54 ±0.82 | 4.398 ±0.76 |
IGT | Serum uric acid (mg/dl) | 6.5±0.2 | 4.398±0.76 |
Type 2 DM | IGT | Controls | |||
Hypouricemia | Positive | 19 | 0 | 6 | |
Negative | 24 | 7 | 44 | ||
Hyperuricemia | Positive | 0 | 7 | 6 | |
Negative | 43 | 0 | 44 |
- The total number of subjects included in this study was 100. Among these 100 subjects. 43 were patients of type 2 DM, 7 were diagnosed to have IGT and 50 were controls. Among the 100 cases studied, there were 22 males and 21 females with type 2 DM. 3 males and 4 females were diagnosed to have IGT and among 50 controls there were 25 males and 25 females
- Serum uric acid in diabetic population and control varied from 2.1 to 4.8 and 3.1 to 5.8mg/dl respectively. The mean and standard deviation of uric acid among diabetics was 3.54±0.819 while in control it was 4.398±0.767 respectively
- Serum uric acid in patients with IGT and control varied from 6.2 to 6.8 and 3.1 to 5.8. The mean and standard deviation of uric acid among cases was 6.5±0.2 while in control it was 4.398±0.767.
- Hypouricemia defined as serum uric acid levels <3.5mg/dl in males and <3.0mg/dl in females. 19 cases of type 2 DM had hypouricemia while 6 in controls
- Hyperuricemia defined as uric acid level>5.5mg/dl in males and 5mg/dl in females 7 cases of IGT had hyperuricemia, 6 controls had hyperuricemia and none in patients with type 2 DM
DISCUSSION
The present study of serum uric acid levels in patients with type 2 DM and in patients found to have impaired glucose tolerance was carried out in department of general medicine. Basaveshwar Teaching and general hospital from April 2017 to March 2018
The patients were grouped into study group (patients with type 2 dm and patients with impaired glucose tolerance) and control group (normal patients). The purpose of the study was to determine the serum uric acid levels in patients with type 2 DM and patients with IGT in comparison with normal subjects
The main findings of our study were that the plasma uric acid levels were elevated in men and women with impaired glucose tolerance the lowest plasma uric acid levels was found in Diabetic patients. plasma uric acid levels will clearly decrease, especially in diabetics men. A negative Association of Plasma uric acid with overt diabetes was found in several other studies 6,7,8,9.
Our results confirm this finding despite the methodological differences and various Diagnostic criteria for diabetes mellitus used in these studies. In a prospective study of 10,000 Israeli men, it was found that a diabetic man had lower plasma uric acid levels than pre-diabetic man, who had higher levels than nondiabetic man10, 11
None of the previously published epidemiologic studies of Plasma uric acid uric acid and diabetes have used the WHO classification for impaired glucose tolerance and diabetes mellitus.our study used the WHO criteria and showed that patients with impaired glucose tolerance have the highest plasma uric acid level .an interesting finding in our study was that plasma uric acid levels Were clearly reduced in Diabetic patients when compared with nondiabetic patients.
In this study mean serum uric acid levels were less in patients with poorly controlled diabetes when compared to patients with well controlled Diabetes. The mean serum uric acid level was 3.09 ± 0.123 and 3.94 ± 0.619 poorly controlled and well-controlled diabetic patients, respectively.
Derek G Cook et.al. show that there was a positive relationship between serum glucose and uric acid concentrations at Higher levels of glucose serum uric acid levels decreased. he concluded that serum uric acid probably reflects the biochemical interaction between serum glucose and purine metabolism with increased excretion of uric acid during hyperglycemia and glycosuria 12.
In our study the mean serum uric acid was high in all patients with IGT when compared to controls and diabetic subjects and the difference was statistically significant.
Kodama S et.al. in their study assessed systematical evaluation of association between serum uric acid levels and subsequent development of type 2 DM and concluded that serum uric acid level is positively associated with the development of type 2 DM regardless of various study characteristics and concluded that further research should we attempted to determine whether it is effective to utilize serum uric acid levels as a predictor for type 2 DM for its primary prevention13.
In this study patients with poor metabolic control and longer duration of diabetes were more susceptible to develop variouscomplications including hypouricemia.
Our study also shows that lower levels of serum uric acid was seen in patients with longer duration of diabetes when compared with shorter duration of diabetes,3.02 ± 1.089 (>9yrs) vs 4.11 ± 1.072 (0 to 4 years) The difference was statistically significant. The possible reason may be due to increased excretion of uric acid over the years and modification of diet in renal disease.
In this study all 100% (7) patients of IGT had raised serum uric acid levels when compared to only 12% (6)in control group and 0% in patients with type 2 DM. The mean value of mean serum uric acid level was 3.54 ± 0.819, 6.5 ± 0.2 and 4.398 ± 0.76 in patients with type 2 DM patients with IGT and controls respectively the results were statistically significant.
CONCLUSION
Serum uric acid concentration is slightly reduced in patients with type 2 DM, particularly in patients with poor glycemic control. This may be due to increased excretion of uric acid during hyperglycemia and glycosuria and modification of diet in renal disease. Serum uric acid concentration is increased in patients with IGT and factors contributing to it are still unclear
REFERENCES
- International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels, Belgium: 2019. Available at: https://www.diabetesatlas.org. Accessed 14 February 2020.
- International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brussels, Belgium: 2019. Accessed 14 February 2020.
- George J, Struthers AD. Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress. Vasc Health Risk Manag. 2009;5:265–72
- Pasalic D, Marinkovic N, Feher-Turkovic L. Uric acid as one of the important factors in multifactorial disorders – facts and controversies. Biochemia Medica. 2012;Vol (Issue):63-75
- Xiong Q, Liu J, Xu Y. Effects of Uric Acid on Diabetes Mellitus and Its Chronic Complications. International Journal of Endocrinology. 2019;Vol (Issue):1-8
- Yamada H, Gabuzda TG. Article title. J. Lab Clin. Med; 1974; 83:477-88.
- American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetic Care 1998; 21 (Suppl 1):5-19.
- Steele T, Rieselbach R. The renal mechanism for urate homeostasis in normal man. The American Journal of Medicine. 1967;43(6):868-75
- Fanelli GM. Urate Excretion. Annual Review of Medicine.1977;28:349-54
- Steele TH, Rieselbach RE. The renal mechanism for urate homeostasis in normal man. Am J Med. 1967 Dec;43(6):868-75.
- Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care. 2008;31(2):361-2.
- Cook D, Shaper A, Thelle D, Whitehead T. Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgraduate Medical Journal. 1986;62(733):1001-1006.
- Kodama S, Saito K, Yachi Y. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32(9):1737-1742.
Published
Issue
Section
License
Copyright (c) 2022 Shivaraj S Hanchinal, Suresh Harsoor
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
What are my rights as an author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to obtain publishing rights without restrictions.
- You may do whatever you wish with the version of the article you submitted to the journal.
- Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
- You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
- You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.